Opportunity Information: Apply for PAR 25 078

The National Institutes of Health, through the National Cancer Institute (NCI), is offering the NCI Small Grants Program for Cancer Research (NCI Omnibus) using the R03 grant mechanism (Funding Opportunity Number PAR-25-078). This opportunity is designed to support small, focused cancer research projects that can be completed in a relatively short timeframe and with limited resources. The overall intent is to give investigators a way to generate preliminary results, test ideas, or produce targeted deliverables that can move a line of cancer research forward without requiring the scale or budget of larger NIH awards. Clinical trials are optional under this NOFO, meaning applicants may propose a clinical trial if appropriate, but it is not required.

Projects supported under an R03 are typically compact and clearly bounded in scope. The announcement highlights several common project types that fit well within this mechanism: pilot and feasibility studies that test early-stage concepts or approaches; secondary analyses of existing datasets where new questions can be answered without collecting entirely new data; small, self-contained research projects that address a specific hypothesis or gap; and efforts focused on research methods, including the development or refinement of research methodology. It also supports development of new research technology, which can include early prototyping, optimization, or proof-of-concept work intended to enable later, more expansive studies in cancer research.

The funding instrument is a grant, and the activity category is listed under Education and Health, with CFDA number 93.393. The award ceiling is $50,000, indicating the maximum amount that can be requested/awarded under the opportunity as provided in the source data. The opportunity is categorized as discretionary funding, and it is administered by the NIH. The original closing date is January 7, 2026, and the opportunity record shows a creation date of October 18, 2024. The number of expected awards is not specified in the provided source.

Eligibility is broad and includes many types of domestic U.S. organizations and governmental entities. Eligible applicants listed include state, county, and city or township governments; special district governments; and independent school districts. Higher education institutions are eligible, including public and state-controlled institutions of higher education as well as private institutions of higher education. Tribal eligibility includes Native American tribal governments that are federally recognized, as well as Native American tribal organizations that are not federally recognized. Housing-related public entities such as public housing authorities and Indian housing authorities are also eligible. Both nonprofit organizations with 501(c)(3) status and nonprofits without 501(c)(3) status (in each case, other than institutions of higher education) may apply. For-profit organizations other than small businesses, as well as small businesses themselves, are included in the eligible applicant types, along with an “Others” category that NIH sometimes uses to capture additional eligible organization types.

In addition, the NOFO explicitly notes other eligible applicant categories that reflect NIH’s interest in inclusive participation across institution types and communities. These include Alaska Native and Native Hawaiian Serving Institutions; Asian American, Native American, and Pacific Islander Serving Institutions (AANAPISIs); Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); and Tribally Controlled Colleges and Universities (TCCUs). It also includes eligible agencies of the federal government, faith-based or community-based organizations, regional organizations, U.S. territories or possessions, and Indian/Native American tribal governments other than federally recognized entities. The announcement further indicates that non-domestic (non-U.S.) entities (foreign organizations) may be eligible as well, which can be important for cancer research questions requiring international populations, samples, or collaborations, depending on NIH policy and the specifics of the proposed work.

In practical terms, this NOFO is best suited for applicants who have a well-defined cancer research question and a realistic plan to complete meaningful work with a modest budget. Competitive projects under the R03 format usually emphasize clear aims, a tight and feasible project plan, and a strong rationale for why a smaller, short-duration study is the right next step, whether the goal is to establish feasibility, validate methods, generate preliminary data for a larger grant, or deliver a narrowly targeted methodological or technological advance relevant to cancer research.

  • The National Institutes of Health in the education, health sector is offering a public funding opportunity titled "NCI Small Grants Program for Cancer Research (NCI Omnibus) (R03 Clinical Trial Optional)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.393.
  • This funding opportunity was created on 2024-10-18.
  • Applicants must submit their applications by 2026-01-07. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Each selected applicant is eligible to receive up to $50,000.00 in funding.
  • Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
Apply for PAR 25 078

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Frequently Asked Questions (FAQs)

What is this funding opportunity?

This opportunity is the National Cancer Institute (NCI) Small Grants Program for Cancer Research (NCI Omnibus) using the NIH R03 grant mechanism. The Funding Opportunity Number is PAR-25-078.

Which agency is offering the grant?

The National Institutes of Health (NIH), through the National Cancer Institute (NCI), is administering this grant opportunity.

What is the purpose of the NCI R03 small grant program?

The program is intended to support small, focused cancer research projects that can be completed in a relatively short timeframe with limited resources. It is meant to help investigators generate preliminary results, test ideas, and produce targeted deliverables that move a line of cancer research forward without the scale or budget of larger NIH awards.

What grant mechanism is being used?

The funding mechanism is the NIH R03 (Small Grant) mechanism.

What types of projects are a good fit for an R03 under this announcement?

Examples of project types highlighted as a good fit include:

  • Pilot and feasibility studies that test early-stage concepts or approaches
  • Secondary analyses of existing datasets to answer new questions without collecting entirely new data
  • Small, self-contained research projects that address a specific hypothesis or gap
  • Research methods projects, including development or refinement of research methodology
  • Development of new research technology, such as early prototyping, optimization, or proof-of-concept work intended to enable later cancer research studies

Are clinical trials required?

No. Clinical trials are optional under this NOFO. Applicants may propose a clinical trial if appropriate, but a clinical trial is not required.

What is the maximum award amount?

The award ceiling listed for this opportunity is $50,000, which is the maximum amount that can be requested/awarded under the opportunity as provided in the source data.

What is the funding instrument and funding type?

The funding instrument is a grant. The opportunity is categorized as discretionary funding.

What is the CFDA number associated with this opportunity?

The CFDA number provided is 93.393.

What activity category is this opportunity listed under?

The activity category is listed as Education and Health.

When is the application deadline?

The original closing date listed is January 7, 2026.

When was this opportunity created?

The opportunity record shows a creation date of October 18, 2024.

How many awards will be made?

The number of expected awards is not specified in the provided information.

Who is eligible to apply?

Eligibility is broad and includes many types of domestic U.S. organizations and governmental entities, as well as additional categories specifically noted by NIH in the announcement.

Which U.S. government entities are eligible?

Eligible government applicants include:

  • State governments
  • County governments
  • City or township governments
  • Special district governments
  • Independent school districts
  • Eligible agencies of the federal government

Are colleges and universities eligible?

Yes. Eligible higher education institutions include public and state-controlled institutions of higher education and private institutions of higher education.

Are minority-serving institutions specifically mentioned as eligible?

Yes. The announcement explicitly notes eligibility for several types of minority-serving institutions, including:

  • Historically Black Colleges and Universities (HBCUs)
  • Hispanic-serving Institutions
  • Tribally Controlled Colleges and Universities (TCCUs)
  • Alaska Native and Native Hawaiian Serving Institutions
  • Asian American, Native American, and Pacific Islander Serving Institutions (AANAPISIs)

Are tribal governments and tribal organizations eligible?

Yes. Eligibility includes Native American tribal governments that are federally recognized as well as Native American tribal organizations that are not federally recognized. The announcement also includes Indian/Native American tribal governments other than federally recognized entities.

Are nonprofits eligible to apply?

Yes. Eligible applicants include nonprofit organizations with 501(c)(3) status (other than institutions of higher education) and nonprofit organizations without 501(c)(3) status (other than institutions of higher education).

Are for-profit organizations eligible?

Yes. For-profit organizations other than small businesses are listed as eligible, and small businesses are also included in the eligible applicant types.

Are public housing authorities eligible?

Yes. Public housing authorities and Indian housing authorities are listed as eligible applicants.

Are faith-based or community-based organizations eligible?

Yes. The announcement includes faith-based or community-based organizations among eligible applicant categories.

Are regional organizations eligible?

Yes. Regional organizations are included among the eligible applicant categories.

Are U.S. territories or possessions eligible?

Yes. U.S. territories or possessions are listed among eligible applicant categories.

Are non-U.S. (foreign) organizations eligible to apply?

Yes. The announcement indicates that non-domestic (non-U.S.) entities (foreign organizations) may be eligible as well.

What does “small, focused” mean in the context of this R03 opportunity?

Projects supported under an R03 are typically compact and clearly bounded in scope, with a realistic plan to complete meaningful work using modest resources. Competitive applications generally emphasize clear aims, feasibility, and a strong rationale for why a short-duration, smaller-budget project is the right next step.

What are common goals for an R03 project under this NOFO?

Common goals include establishing feasibility, validating methods, generating preliminary data for a larger grant application, or delivering a narrowly targeted methodological or technological advance relevant to cancer research.

Is this opportunity only for cancer research?

Based on the information provided, the opportunity is specifically for cancer research and is offered through the National Cancer Institute.

What is the official identifier for this funding opportunity?

The Funding Opportunity Number is PAR-25-078.

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Education, Health

Next opportunity: Advancement and Innovation in Measurement of Language Development and Predictors (R01 Clinical Trial Not Allowed)

Previous opportunity: New Therapeutic Strategies for Genital Herpes (R21/R33 Clinical Trial Not Allowed)

Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for PAR 25 078

 

Applicants also applied for:

Applicants who have applied for this opportunity (PAR 25 078) also looked into and applied for these:

Funding Opportunity
The Metastasis Research Network (MetNet): MetNet Research Projects (U01 Clinical Trial Not Allowed) Apply for PAR 25 130

Funding Number: PAR 25 130
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $500,000
Targeting Inflammasomes in HIV and Substance Use (R21 Clinical Trial Not Allowed) Apply for RFA DA 25 068

Funding Number: RFA DA 25 068
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $500,000
Computational Approaches to Curation at Scale for Biomedical Research Assets (R01 Clinical Trial Not Allowed) Apply for PAR 25 131

Funding Number: PAR 25 131
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $250,000
Targeting Inflammasomes in HIV and Substance Use (R01 Clinical Trial Not Allowed) Apply for RFA DA 25 069

Funding Number: RFA DA 25 069
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $500,000
Biomedical Research Environment and Sponsored Programs Administration Development (BRE-SPAD) Program (UC2- Clinical Trial Not Allowed) Apply for PAR 24 268

Funding Number: PAR 24 268
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $500,000
Mechanistic links between diet, lipid metabolism, and tumor growth and progression (UH2 Clinical Trial Not Allowed) Apply for PAR 25 118

Funding Number: PAR 25 118
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Enhancing Mechanistic Research on Precision Probiotic Therapies (R61/R33 Clinical Trial Optional) Apply for PAR 25 211

Funding Number: PAR 25 211
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Enhancing Mechanistic Research on Precision Probiotic Therapies (R33 Clinical Trial Optional) Apply for PAR 25 210

Funding Number: PAR 25 210
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Mechanistic links between diet, lipid metabolism, and tumor growth and progression (U01 Clinical Trial Not Allowed) Apply for PAR 25 119

Funding Number: PAR 25 119
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
NCI Clinical and Translational Exploratory/Developmental Studies (R21 Clinical Trial Optional) Apply for PAR 25 139

Funding Number: PAR 25 139
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $275,000
Addressing Challenges in Detecting New Drugs: Instrumentation for Alternative Analytical Methods (R43/R44 - Clinical Trials Optional) Apply for RFA DA 26 018

Funding Number: RFA DA 26 018
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Addressing Challenges in Detecting New Drugs: Instrumentation for Alternative Analytical Methods (R41/R42 - Clinical Trials Optional) Apply for RFA DA 26 019

Funding Number: RFA DA 26 019
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Cancer Prevention and Control Clinical Trials Planning Grant Program (R34 Clinical Trials Optional) Apply for PAR 25 104

Funding Number: PAR 25 104
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Cancer Prevention and Control Clinical Trials Planning Grant Program (U34 Clinical Trials Optional) Apply for PAR 25 103

Funding Number: PAR 25 103
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Engaging Loved ones in Recovery Processes to Enhance Recovery Capital and Outcomes (R61/R33 Clinical Trial Optional) Apply for RFA DA 26 024

Funding Number: RFA DA 26 024
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Research Projects to Enhance Applicability of Mammalian Models for Translational Research (R01 Clinical Trial Not Allowed) Apply for PAR 24 306

Funding Number: PAR 24 306
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $499,000
Integration of Imaging and Fluid-Based Tumor Monitoring in Cancer Therapy (R01 Clinical Trial Optional) Apply for PAR 25 175

Funding Number: PAR 25 175
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $500,000
Molecular Imaging of Inflammation in Cancer (R01 Clinical Trial Not Allowed) Apply for PAR 24 311

Funding Number: PAR 24 311
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $500,000
Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies (R01 Clinical Trial Optional) Apply for PAR 25 145

Funding Number: PAR 25 145
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Assay development and screening for discovery of chemical probes, drugs or immunomodulators (R01 Clinical Trial Not Allowed) Apply for PAR 25 153

Funding Number: PAR 25 153
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

Inside Our Applicants Portal

  • Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
  • Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
  • Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Access Applicants Portal

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Learn More

 

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "PAR 25 078", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.

 

Ask a Question: